Does the media refer more to IRTC or SOLV?

In the previous week, Solventum had 1 more articles in the media than iRhythm Technologies. MarketBeat recorded 6 mentions for Solventum and 5 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.79 beat Solventum's score of 0.38 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Solventum 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, SNN or IRTC?

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Smith & Nephew SNATS $6.16B 2.07 $625M N/A N/A iRhythm Technologies $747.14M 4.49 -$44.55M -$0.86 N/A

Does the media favor SNN or IRTC?

In the previous week, iRhythm Technologies had 4 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 5 mentions for iRhythm Technologies and 1 mentions for Smith & Nephew SNATS. iRhythm Technologies' average media sentiment score of 0.79 beat Smith & Nephew SNATS's score of 0.00 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew SNATS 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral iRhythm Technologies 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PEN or IRTC?

In the previous week, iRhythm Technologies had 3 more articles in the media than Penumbra. MarketBeat recorded 5 mentions for iRhythm Technologies and 2 mentions for Penumbra. Penumbra's average media sentiment score of 1.19 beat iRhythm Technologies' score of 0.79 indicating that Penumbra is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to IRTC or GKOS?

In the previous week, iRhythm Technologies had 2 more articles in the media than Glaukos. MarketBeat recorded 5 mentions for iRhythm Technologies and 3 mentions for Glaukos. iRhythm Technologies' average media sentiment score of 0.79 beat Glaukos' score of -0.27 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Glaukos 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer STVN or IRTC?

iRhythm Technologies has a consensus price target of $189.69, suggesting a potential upside of 85.70%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts clearly believe iRhythm Technologies is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.67 iRhythm Technologies 1 Sell rating(s) 1 Hold rating(s) 12 Buy rating(s) 2 Strong Buy rating(s) 2.94

Does the media refer more to STVN or IRTC?

In the previous week, iRhythm Technologies had 1 more articles in the media than Stevanato Group. MarketBeat recorded 5 mentions for iRhythm Technologies and 4 mentions for Stevanato Group. iRhythm Technologies' average media sentiment score of 0.79 beat Stevanato Group's score of 0.67 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

iRhythm Technologies (IRTC) Competitors

$102.15 -3.35 (-3.18%)

As of 01:04 PM Eastern

Compare

IRTC vs. SOLV, SNN, PEN, GKOS, and STVN

Should you buy iRhythm Technologies stock or one of its competitors? MarketBeat compares iRhythm Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with iRhythm Technologies include Solventum (SOLV), Smith & Nephew SNATS (SNN), Penumbra (PEN), Glaukos (GKOS), and Stevanato Group (STVN). These companies are all part of the "medical equipment" industry.

How does iRhythm Technologies compare to Solventum?

iRhythm Technologies (NASDAQ:IRTC) and Solventum (NYSE:SOLV) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

Solventum has a net margin of 17.33% compared to iRhythm Technologies' net margin of -3.53%. Solventum's return on equity of 23.51% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Solventum	17.33%	23.51%	7.63%

iRhythm Technologies presently has a consensus price target of $189.69, indicating a potential upside of 85.70%. Solventum has a consensus price target of $84.25, indicating a potential upside of 8.35%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe iRhythm Technologies is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Solventum	1 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.50

iRhythm Technologies has a beta of 1.27, suggesting that its stock price is 27% more volatile than the broader market. Comparatively, Solventum has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market.

In the previous week, Solventum had 1 more articles in the media than iRhythm Technologies. MarketBeat recorded 6 mentions for Solventum and 5 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.79 beat Solventum's score of 0.38 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Solventum	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Solventum has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.49	-$44.55M	-$0.86	N/A
Solventum	$8.33B	1.62	$1.56B	$8.16	9.53

Summary

Solventum beats iRhythm Technologies on 8 of the 15 factors compared between the two stocks.

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Smith & Nephew SNATS (NYSE:SNN) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

Smith & Nephew SNATS has a net margin of 0.00% compared to iRhythm Technologies' net margin of -3.53%. Smith & Nephew SNATS's return on equity of 0.00% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew SNATS	N/A	N/A	N/A
iRhythm Technologies	-3.53%	-10.26%	-1.39%

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew SNATS	$6.16B	2.07	$625M	N/A	N/A
iRhythm Technologies	$747.14M	4.49	-$44.55M	-$0.86	N/A

Smith & Nephew SNATS has a beta of 0.55, indicating that its stock price is 45% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market.

In the previous week, iRhythm Technologies had 4 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 5 mentions for iRhythm Technologies and 1 mentions for Smith & Nephew SNATS. iRhythm Technologies' average media sentiment score of 0.79 beat Smith & Nephew SNATS's score of 0.00 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smith & Nephew SNATS	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
iRhythm Technologies	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

25.6% of Smith & Nephew SNATS shares are held by institutional investors. 1.0% of Smith & Nephew SNATS shares are held by insiders. Comparatively, 1.0% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Smith & Nephew SNATS presently has a consensus target price of $30.93, indicating a potential upside of 3.32%. iRhythm Technologies has a consensus target price of $189.69, indicating a potential upside of 85.70%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts clearly believe iRhythm Technologies is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew SNATS	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

Summary

iRhythm Technologies beats Smith & Nephew SNATS on 8 of the 15 factors compared between the two stocks.

How does iRhythm Technologies compare to Penumbra?

Penumbra (NYSE:PEN) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

Penumbra has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.40B	8.93	$177.69M	$4.34	73.45
iRhythm Technologies	$747.14M	4.49	-$44.55M	-$0.86	N/A

Penumbra has a net margin of 11.76% compared to iRhythm Technologies' net margin of -3.53%. Penumbra's return on equity of 10.87% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	11.76%	10.87%	8.45%
iRhythm Technologies	-3.53%	-10.26%	-1.39%

Penumbra has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.27, suggesting that its stock price is 27% more volatile than the broader market.

Penumbra presently has a consensus price target of $361.33, suggesting a potential upside of 13.35%. iRhythm Technologies has a consensus price target of $189.69, suggesting a potential upside of 85.70%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

In the previous week, iRhythm Technologies had 3 more articles in the media than Penumbra. MarketBeat recorded 5 mentions for iRhythm Technologies and 2 mentions for Penumbra. Penumbra's average media sentiment score of 1.19 beat iRhythm Technologies' score of 0.79 indicating that Penumbra is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
iRhythm Technologies	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

88.9% of Penumbra shares are owned by institutional investors. 2.9% of Penumbra shares are owned by insiders. Comparatively, 1.0% of iRhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Penumbra beats iRhythm Technologies on 11 of the 17 factors compared between the two stocks.

How does iRhythm Technologies compare to Glaukos?

iRhythm Technologies (NASDAQ:IRTC) and Glaukos (NYSE:GKOS) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

In the previous week, iRhythm Technologies had 2 more articles in the media than Glaukos. MarketBeat recorded 5 mentions for iRhythm Technologies and 3 mentions for Glaukos. iRhythm Technologies' average media sentiment score of 0.79 beat Glaukos' score of -0.27 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Glaukos	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

iRhythm Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Glaukos has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

iRhythm Technologies has higher revenue and earnings than Glaukos. iRhythm Technologies is trading at a lower price-to-earnings ratio than Glaukos, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.49	-$44.55M	-$0.86	N/A
Glaukos	$507.44M	12.96	-$187.69M	-$3.28	N/A

99.0% of Glaukos shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 5.9% of Glaukos shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

iRhythm Technologies currently has a consensus target price of $189.69, indicating a potential upside of 85.70%. Glaukos has a consensus target price of $146.17, indicating a potential upside of 30.53%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts clearly believe iRhythm Technologies is more favorable than Glaukos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Glaukos	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.79

iRhythm Technologies has a net margin of -3.53% compared to Glaukos' net margin of -34.34%. Glaukos' return on equity of -6.92% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Glaukos	-34.34%	-6.92%	-5.25%

Summary

iRhythm Technologies beats Glaukos on 11 of the 16 factors compared between the two stocks.

How does iRhythm Technologies compare to Stevanato Group?

Stevanato Group (NYSE:STVN) and iRhythm Technologies (NASDAQ:IRTC) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Stevanato Group has a net margin of 11.76% compared to iRhythm Technologies' net margin of -3.53%. Stevanato Group's return on equity of 10.27% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.76%	10.27%	6.08%
iRhythm Technologies	-3.53%	-10.26%	-1.39%

iRhythm Technologies has a consensus price target of $189.69, suggesting a potential upside of 85.70%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts clearly believe iRhythm Technologies is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

In the previous week, iRhythm Technologies had 1 more articles in the media than Stevanato Group. MarketBeat recorded 5 mentions for iRhythm Technologies and 4 mentions for Stevanato Group. iRhythm Technologies' average media sentiment score of 0.79 beat Stevanato Group's score of 0.67 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
iRhythm Technologies	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Stevanato Group has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market.

Stevanato Group has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.20B	4.66	€158.21M	€0.59	31.37
iRhythm Technologies	$747.14M	4.49	-$44.55M	-$0.86	N/A

Summary

Stevanato Group beats iRhythm Technologies on 8 of the 15 factors compared between the two stocks.

Get iRhythm Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRTC vs. The Competition

Export

Metric	iRhythm Technologies	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.36B	$1.54B	$6.26B	$12.40B
Dividend Yield	N/A	N/A	2.69%	5.29%
P/E Ratio	-118.78	77.59	22.37	24.16
Price / Sales	4.49	23.52	547.57	124.65
Price / Cash	N/A	23.15	42.31	57.88
Price / Book	21.55	4.75	9.79	6.69
Net Income	-$44.55M	-$54.76M	$3.56B	$336.98M
7 Day Performance	-8.30%	-0.58%	-1.27%	0.45%
1 Month Performance	-15.44%	4.81%	3.58%	4.95%
1 Year Performance	-29.54%	-3.31%	27.13%	34.01%

iRhythm Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRTC iRhythm Technologies	4.0368 of 5 stars	$102.15 -3.2%	$189.69 +85.7%	-25.0%	$3.36B	$747.14M	N/A	2,400	Analyst Forecast
SOLV Solventum	3.016 of 5 stars	$75.13 -1.1%	$84.25 +12.1%	+4.5%	$13.15B	$8.26B	9.21	20,000	High Trading Volume
SNN Smith & Nephew SNATS	1.8213 of 5 stars	$29.72 -0.2%	$30.93 +4.1%	+0.8%	$12.71B	$6.16B	N/A	16,988
PEN Penumbra	2.1736 of 5 stars	$318.46 -0.2%	$361.33 +13.5%	+24.2%	$12.54B	$1.40B	73.38	4,700	Positive News
GKOS Glaukos	2.8204 of 5 stars	$103.08 -3.2%	$146.17 +41.8%	+17.1%	$6.26B	$507.44M	N/A	1,094

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRTC) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

iRhythm Technologies (IRTC) Competitors

IRTC vs. SOLV, SNN, PEN, GKOS, and STVN

How does iRhythm Technologies compare to Solventum?

Summary

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Summary

How does iRhythm Technologies compare to Penumbra?

Summary

How does iRhythm Technologies compare to Glaukos?

Summary

How does iRhythm Technologies compare to Stevanato Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRTC vs. The Competition

iRhythm Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

iRhythm Technologies (IRTC) Competitors

IRTC vs. SOLV, SNN, PEN, GKOS, and STVN

How does iRhythm Technologies compare to Solventum?

Is IRTC or SOLV more profitable?

Do analysts prefer IRTC or SOLV?

Which has more risk & volatility, IRTC or SOLV?

Does the media refer more to IRTC or SOLV?

Which has preferable valuation & earnings, IRTC or SOLV?

Summary

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Is SNN or IRTC more profitable?

Which has preferable valuation and earnings, SNN or IRTC?

Which has more risk and volatility, SNN or IRTC?

Does the media favor SNN or IRTC?

Do insiders and institutionals believe in SNN or IRTC?

Do analysts rate SNN or IRTC?

Summary

How does iRhythm Technologies compare to Penumbra?

Which has stronger earnings and valuation, PEN or IRTC?

Is PEN or IRTC more profitable?

Which has more volatility and risk, PEN or IRTC?

Do analysts recommend PEN or IRTC?

Does the media favor PEN or IRTC?

Do institutionals & insiders hold more shares of PEN or IRTC?

Summary

How does iRhythm Technologies compare to Glaukos?

Does the media refer more to IRTC or GKOS?

Which has more volatility and risk, IRTC or GKOS?

Which has preferable earnings & valuation, IRTC or GKOS?

Do institutionals and insiders have more ownership in IRTC or GKOS?

Do analysts prefer IRTC or GKOS?

Is IRTC or GKOS more profitable?

Summary

How does iRhythm Technologies compare to Stevanato Group?

Is STVN or IRTC more profitable?

Do analysts prefer STVN or IRTC?

Does the media refer more to STVN or IRTC?

Which has more risk and volatility, STVN or IRTC?

Which has better earnings and valuation, STVN or IRTC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRTC vs. The Competition

iRhythm Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools